share_log

HC Wainwright & Co. Reiterates Buy on Agile Therapeutics, Maintains $12 Price Target

Benzinga ·  Jun 26, 2023 06:11

HC Wainwright & Co. analyst Oren Livnat reiterates Agile Therapeutics (NASDAQ:AGRX) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment